State Medicaid agencies can improve D-SNP financial transparency and reward those D-SNPs that provide the best value to ...

We recently published a list of 10 Tech Stocks with High Upside Potential. In this article, we are going to take a look at ...

Synopsys SNPS shares plunged 20.8% over the past year, underperforming the Zacks Computer - Software industry, Zacks Computer ...

Synopsys (SNPS), a company that provides software for designing computer chips, is planning to sell around $10 billion worth of bonds as early ...

Synopsys (NASDAQ:SNPS – Free Report) had its price target decreased by Piper Sandler from $655.00 to $653.00 in a report released on Thursday,Benzinga reports. Piper Sandler currently has an ...

This post was written by Luke Carberry Mogan. SNPS' first-quarter performance is likely to have benefited from the rising adoption of EDA, IP solutions and Synopsys.ai platform. Get a deeper ...

Wells Fargo analyst Joe Quatrochi lowered the firm’s price target on Synopsys (SNPS) to $520 from $540 and keeps an Equal Weight rating on the ...

Software company Synopsys (SNPS) continues to show strong performance, with a beat on first quarter fiscal year earnings and a reaffirmed outlook for double-digit revenue growth. The company's focus ...

Synopsys SNPS delivered better-than-expected first-quarter fiscal 2025 results. The company reported non-GAAP earnings of $3.03 per share for the first quarter, surpassing the Zacks Consensus ...

Synopsys (SNPS) ended the recent trading session at $493.97, demonstrating a -1.4% swing from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.43%. Elsewhere ...

A comprehensive national study examining dementia patient outcomes for Medicare Advantage beneficiaries with Alzheimer's disease and related dementias (ADRD) uncovered key insights into healthcare ...